FLT3 and acute myeloid leukemia: For example, in some AML cases, autophagy has been shown to be critical for degradation of oncogenic drivers, such as mutant FLT3, and during drug-induced myeloid or neutrophil differentiation therapies, suggesting that autophagy initiation is beneficial in certain contexts [52,53,159].